# Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial

> **NCT06303622** · NA · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 1250 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** MRI-USG fusion approach
- **PROCEDURE:** Cognitive-guided approach

## Key facts

- **NCT ID:** NCT06303622
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-08
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 1250 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06303622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06303622, "Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06303622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*